Quick Answer
Hims & Hers Health, Inc. reported Stockholders Equity of $540.93 million for the year ending 2025.
- Hims & Hers Health, Inc. showed an increase of +13.5% in Stockholders Equity from 2024 to 2025.
- This data is from Hims & Hers Health, Inc.'s annual report (Form 10-K), filed with the SEC on February 23, 2026.
- XBRL data for this metric is available from 2018 to 2025 (9 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2019: $8.4 thousand | Q3 2019: $5.00 million | Q1 2020: -$139.95 million | Q2 2020: -$138.95 million | Q3 2020: -$143.34 million | Q1 2021: $292.47 million | Q2 2021: $293.05 million | Q3 2021: $355.15 million | Q1 2022: $327.72 million | Q2 2022: $319.06 million | Q3 2022: $310.95 million | Q1 2023: $312.75 million | Q2 2023: $320.07 million | Q3 2023: $328.56 million | Q1 2024: $344.48 million | Q2 2024: $361.97 million | Q3 2024: $440.05 million | Q1 2025: $549.26 million | Q2 2025: $562.70 million | Q3 2025: $580.98 million.
- Over the full 9 years of available data (2018 to 2025), Hims & Hers Health, Inc.'s Stockholders Equity has grown by 858.1%.
- Historical annual values: Fiscal year 2025: $540.93 million | Fiscal year 2024: $476.72 million | Fiscal year 2023: $344.03 million | Fiscal year 2022: $311.74 million | Fiscal year 2021: $334.62 million | Fiscal year 2020: -$146.87 million | Fiscal year 2019: -$139.79 million | Fiscal year 2019: $0.00 | Fiscal year 2018: -$71.36 million.
- Data sourced from SEC EDGAR public filings as of August 9, 2026.
Last verified: